{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:55:06Z","timestamp":1791428106846,"version":"4.3.3"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087696","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T17:50:46Z","timestamp":1393609846000},"page":"e87696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["In Their Own Words: Treating Very Young BRCA1\/2 Mutation-Positive Women with Care and Caution"],"prefix":"10.1371","volume":"9","author":[{"given":"Lindsey M.","family":"Hoskins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Werner-Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10911-011-9200-x","article-title":"Clinical management of hereditary breast cancer syndromes","volume":"16","author":"AS Clark","year":"2011","journal-title":"J Mammary Gland Biol"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> penetrance","volume":"25","author":"S Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutations in a large United States sample","volume":"24","author":"S Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/BD-2006-23104","article-title":"Genetics and the young woman with breast cancer","volume":"23","author":"JP Evans","year":"2005","journal-title":"Breast Disease"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/B:JOGC.0000018821.48330.77","article-title":"Genetic cancer risk assessment and counseling: Recommendations of the National Society of Genetic Counselors","volume":"13","author":"A Trepanier","year":"2004","journal-title":"J Genet Counseling"},{"key":"ref6","unstructured":"Arnett JJ (2004) Emerging Adulthood: The Winding Road from the Late Teens through the Twenties. Oxford, UK, Oxford University Press."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/BD-2006-23105","article-title":"Prophylaxis and screening options: Recommendations for young women with <italic>BRCA<\/italic> mutations","volume":"23","author":"JC Samuel","year":"2005","journal-title":"Breast Disease"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2003.10.100","article-title":"Long-term psychological impact of carrying a <italic>BRCA1\/2<\/italic> mutation and prophylactic surgery: A 5-year follow-up study","volume":"21","author":"I Van Oostrom","year":"2003","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.bjc.6602207","article-title":"Psychosocial impact of breast\/ovarian (<italic>BRCA1\/2<\/italic>) cancer-predictive genetic testing in a UK multi-centre clinical cohort","volume":"91","author":"M Watson","year":"2004","journal-title":"Brit J Cancer"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1545-5300.2007.00215.x","article-title":"Danger zones: Risk perceptions of young women from families with hereditary breast and ovarian cancer","volume":"46","author":"A Werner Lin","year":"2007","journal-title":"Fam Process"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/00981380802173509","article-title":"Beating the biological clock: The compressed family life cycle of young women with <italic>BRCA<\/italic> mutations","volume":"47","author":"A Werner-Lin","year":"2008","journal-title":"Soc Work Health Care"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/07347330802359776","article-title":"Formal and informal support needs of young women with <italic>BRCA<\/italic> mutations","volume":"26","author":"A Werner-Lin","year":"2008","journal-title":"J Psychosoc Oncol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5243\/jsswr.2010.3","article-title":"Building the cancer family: Family planning in the context of inherited breast and ovarian cancer risk","volume":"1","author":"A Werner-Lin","year":"2010","journal-title":"J Society for Soc Work and Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1037\/a0012914","article-title":"Disclosure of positive <italic>BRCA1\/2-<\/italic>mutation status in young couples: The journal from uncertainty to bonding through partner support","volume":"26","author":"LM Hoskins","year":"2008","journal-title":"Fam Syst Health"},{"key":"ref15","unstructured":"Hoskins LM (2010) Negotiation of health risks and risk management for young adult <italic>BRCA1\/2-<\/italic>positive women: Implications for partnering and family formation. College Park, MD: UMCP."},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1177\/1049732312458182","article-title":"Anticipatory loss and early mastectomy for young female <italic>BRCA1\/2<\/italic> mutation carriers","volume":"22","author":"LM Hoskins","year":"2012","journal-title":"Qual Health Res"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/a0027276","article-title":"Toward a new understanding of risk perception among young female <italic>BRCA1\/2<\/italic> \u2018previvors.\u2019","volume":"30","author":"LM Hoskins","year":"2012","journal-title":"Fam, Syst, Health"},{"key":"ref18","unstructured":"Facing Our Risk of Cancer Empowered, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.facingourrisk.org\" xlink:type=\"simple\">http:\/\/www.facingourrisk.org<\/ext-link>"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: Breast and ovarian","volume":"8","author":"MB Daly","year":"2010","journal-title":"J Nat Comp Cancer Network"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10897-007-9132-1","article-title":"How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: Systematic review","volume":"17","author":"S Sivell","year":"2008","journal-title":"J Genet Counseling"},{"issue":"4\u20135","key":"ref21","first-page":"279","article-title":"Communicating genetic and genomic information: Health literacy and numeracy considerations","volume":"14","author":"DH Lea","year":"2011","journal-title":"Public Health Genomics"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","article-title":"Oral contraceptive use and breast or ovarian cancer risk in <italic>BRCA1\/2<\/italic> carriers: A meta-analysis","volume":"46","author":"S Iodice","year":"2010","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"19.e1","DOI":"10.1016\/j.ajog.2010.05.038","article-title":"Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in <italic>BRCA1\/2<\/italic> mutation carriers?","volume":"204","author":"MH Greene","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1363459312442420","article-title":"\u2018Cancer doesn&apos;t have an age\u2019: Genetic testing and cancer risk management in <italic>BRCA1\/2<\/italic> mutation-positive women aged 18\u201324","volume":"16","author":"A Werner-Lin","year":"2012","journal-title":"Health"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ypmed.2006.06.003","article-title":"Breast cancer screening behaviors among African American women with a strong family history of breast cancer","volume":"43","author":"CH Halbert","year":"2006","journal-title":"Prev Med"},{"issue":"15","key":"ref26","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","article-title":"Genetic testing in an ethnically diverse cohort of high-risk women: A comparative analysis of <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutations in American families of European and African ancestry","volume":"294","author":"R Nanda","year":"2005","journal-title":"J Amer Med Assoc"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/mcp.2010.0414","article-title":"Identification and management of women with <italic>BRCA<\/italic> mutations or hereditary predisposition for Breast and Ovarian Cancer","volume":"85","author":"S Pruthi","year":"2010","journal-title":"Mayo Clinic Proc"},{"issue":"5 Part 1","key":"ref28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","article-title":"Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"LL Humphrey","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/djn440","article-title":"Estimated risk of radiation-induced breast cancer from mammographic screening for young <italic>BRCA<\/italic> mutation carriers","volume":"101","author":"A Berrington de Gonzalez","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1470-2045(06)70624-6","article-title":"Screening mammography and risk of breast cancer in <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutation carriers: a case-control study","volume":"7","author":"SA Narod","year":"2006","journal-title":"Lancet Oncol"},{"issue":"13","key":"ref31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","article-title":"Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers","volume":"92","author":"MT Mandelson","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/jnci\/83.4.260","article-title":"Breast self-examination in relation to the occurrence of advanced breast cancer","volume":"83","author":"PA Newcomb","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"B Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer","volume":"91","author":"MH Gail","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"ref35","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","article-title":"American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including Tamoxifen, Raloxifene, and aromatase inhibition for breast cancer risk reduction","volume":"27","author":"K Visvanathan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutation carriers: The PROSE study group","volume":"22","author":"TR Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic>","volume":"12","author":"N Petrucelli","year":"2010","journal-title":"Genet Med"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","article-title":"<italic>BRCA<\/italic> mutation in the management of breast cancer: the state of the art","volume":"7","author":"SA Narod","year":"2002","journal-title":"Nat Rev Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of <italic>BRCA1-<\/italic> and <italic>BRCA2<\/italic>-associated breast and gynecologic cancer: A multicenter, prospective study","volume":"26","author":"ND Kauff","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: Theories and realities","volume":"3","author":"CP Crum","year":"2009","journal-title":"Mol Oncol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"The incidence of endometrial cancer in women with <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutations: An international prospective cohort study","volume":"130","author":"Y Segev","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1055-9965.EPI-08-0546","article-title":"Reproductive and hormonal factors, and ovarian cancer risk for <italic>BRCA1<\/italic> and <italic>BRCA2<\/italic> mutation carriers: Results from the international <italic>BRCA1\/2<\/italic> Carrier Cohort Study","volume":"18","author":"AC Antoniou","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:23:12Z","timestamp":1565216592000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087696"}},"subtitle":[],"editor":[{"given":"Redhwan Ahmed Al","family":"Naggar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087696","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}